Patents by Inventor Sandrine Gremlich

Sandrine Gremlich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of diabetes with milk protein hydrolysate
    Patent number: 8710003
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: April 29, 2014
    Assignee: Nestec S.A.
    Inventors: Raylene Alison Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser
  • Acid soluble proteins from micellar casein
    Patent number: 8686116
    Abstract: The present invention relates to a milk fraction obtainable by acidification of micellar casein and separation from precipitated casein named acid soluble protein from micellar casein. It was found that the milk fraction and especially certain sub-fractions thereof are bioactive and promote GLP-1 release in vitro. Based on these results, acid soluble protein from micellar casein may be useful in the treatment and the prevention of diabetes type II, obesity and may further be added to formulas directed at other purposes addressing the gastro-intestinal tract.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: April 1, 2014
    Assignee: Nestec S.A.
    Inventors: Sandrine Gremlich, Lionel Bovetto, Catherine Mace
  • TREATMENT OF DIABETES WITH MILK PROTEIN HYDROLYSATE
    Publication number: 20100297253
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Application
    Filed: May 18, 2010
    Publication date: November 25, 2010
    Inventors: Raylene Alison REIMER, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser
  • ACID SOLUBLE PROTEINS FROM MICELLAR CASEIN
    Publication number: 20100111933
    Abstract: The present invention relates to a milk fraction obtainable by acidification of micellar casein and separation from precipitated casein named acid soluble protein from micellar casein. It was found that the milk fraction and especially certain sub-fractions thereof are bioactive and promote GLP-1 release in vitro. Based on these results, acid soluble protein from micellar casein may be useful in the treatment and the prevention of diabetes type II, obesity and may further be added to formulas directed at other purposes addressing the gastro-intestinal tract.
    Type: Application
    Filed: October 23, 2009
    Publication date: May 6, 2010
    Inventors: Sandrine GREMLICH, Lionel Bovetto, Catherine Mace
  • Acid soluble proteins from micellar casein
    Patent number: 7629442
    Abstract: The present invention relates to a milk fraction obtainable by acidification of micellar casein and separation from precipitated casein named acid soluble protein from micellar casein. It was found that the milk fraction and especially certain sub-fractions thereof are bioactive and promote GLP-1 release in vitro. Based on these results, acid soluble protein from micellar casein may be useful in the treatment and the prevention of diabetes type II, obesity and may further be added to formulas directed at other purposes addressing the gastro-intestinal tract.
    Type: Grant
    Filed: August 30, 2003
    Date of Patent: December 8, 2009
    Assignee: Nestec S.A.
    Inventors: Sandrine Gremlich, Lionel Bovetto, Catherine Mace
  • Treatment of diabetes with milk protein hydrolysate
    Patent number: 7585618
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Grant
    Filed: April 19, 2005
    Date of Patent: September 8, 2009
    Assignee: Nestec S.A.
    Inventors: Raylene Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser
  • Acid soluble proteins from micellar casein
    Publication number: 20060276632
    Abstract: The present invention relates to a milk fraction obtainable by acidification of micellar casein and separation from precipitated casein named acid soluble protein from micellar casein. It was found that the milk fraction and especially certain sub-fractions thereof are bioactive and promote GLP-1 release in vitro. Based on these results, acid soluble protein from micellar casein may be useful in the treatment and the prevention of diabetes type II, obesity and may further be added to formulas directed at other purposes addressing the gastro-intestinal tract.
    Type: Application
    Filed: August 30, 2003
    Publication date: December 7, 2006
    Inventors: Sandrine Gremlich, Lionel Bovetto, Catherine Mace
  • Treatment of diabetes with milk protein hydrolysate
    Publication number: 20050186558
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Application
    Filed: April 19, 2005
    Publication date: August 25, 2005
    Inventors: Raylene Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser
  • Treatment of diabetes with milk protein hydrolysate
    Publication number: 20030004095
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Application
    Filed: May 21, 2002
    Publication date: January 2, 2003
    Inventors: Raylene Alison Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser